Attovia Therapeutics, Inc. Common Stock Tangible Net Worth Ratio
Attovia Therapeutics, Inc. Common Stock tangible net worth ratio. Attovia Therapeutics, Inc. Common Stock (ATTO) has a Tangible Net Worth Ratio of 100.0% as of June 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($112.77 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Attovia Therapeutics, Inc. Common Stock equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Attovia Therapeutics, Inc. Common Stock (2024–2025)
Tangible net worth ratio of Attovia Therapeutics, Inc. Common Stock from 2024 to 2025. This chart shows how Attovia Therapeutics, Inc. Common Stock's Tangible Net Worth Ratio has changed across 2 annual periods from 2024 to 2025. As of June 2026, the ratio stands at 100.0%, reflecting net assets of $112.77 Million with intangible assets of $0.00 USD.
Attovia Therapeutics, Inc. Common Stock Tangible Net Worth Ratio by Year (2024–2025)
Attovia Therapeutics, Inc. Common Stock tangible net worth ratio by year from 2024 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Attovia Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see ATTO company net worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $150.79 Million | $0.00 | $165.89 Million | ▲ +0.0 pp |
| 2024 | 100.0% | $62.13 Million | $0.00 | $76.72 Million | — |